Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles

被引:124
作者
Esmaeili, Farnaz
Hosseini-Nasr, Mahdi
Rad-Malekshahi, Mazda
Samadi, Nasrin
Atyabi, Fatemeh
Dinarvand, Rassoul [1 ]
机构
[1] Med Sci Univ Tehran, Dept Pharmaceut, Fac Pharm, Novel Drug Delivery Syst Lab, Tehran, Iran
[2] Med Sci Univ Tehran, Fac Pharm, Drug & Food Control Dept, Tehran, Iran
[3] Med Sci Univ Tehran, Med Nanotechnol Res Ctr, Tehran, Iran
关键词
rifampicin; nanoparticles; antimicrobial delivery; antibacterial activity; poly lactide-co-glycolide;
D O I
10.1016/j.nano.2007.03.003
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Biodegradable polymers such as poly lactide-co-glycolides (PLGA) have been considered for the preparation of nanoparticles (NPs). In this study, rifampicin (RIF)-loaded PLGA NPs were fabricated by an emulsification/solvent diffusion method. The effect of several variables on the NPs' characteristics were evaluated, including the amount of RIF, amount of the poly vinyl alcohol as surfactant, and internal-phase volume and composition. The RIF encapsulation efficacy and the particle size distribution were optimized by varying these parameters. NPs were spherical with a relatively monodispersed size distribution. The effect of nanoencapsulation of RIF on the antibacterial activity of RIF against gram-positive and gram-negative bacteria was evaluated. It was shown that RIF NPs could considerably improve the RIF antibacterial efficacy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 27 条
[1]   ENCAPSULATION OF WATER-SOLUBLE DRUGS BY A MODIFIED SOLVENT EVAPORATION METHOD .1. EFFECT OF PROCESS AND FORMULATION VARIABLES ON DRUG ENTRAPMENT [J].
ALEX, R ;
BODMEIER, R .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :347-355
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]  
[Anonymous], 1992, ADV PHARM S
[4]   Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis [J].
Bivas-Benita, M ;
van Meijgaarden, KE ;
Franken, KLMC ;
Junginger, HE ;
Borchard, G ;
Ottenhoff, THM ;
Geluk, A .
VACCINE, 2004, 22 (13-14) :1609-1615
[5]   Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[6]  
Centers for Disease Control, 1990, MMWR, V39, P718
[7]   Thermodynamic parameters on poly(D,L-lactide-co-glycolide) particle size in emulsification-diffusion process [J].
Choi, SW ;
Kwon, HY ;
Kim, WS ;
Kim, JH .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2002, 201 (1-3) :283-289
[8]  
Couvreur P., 1996, MICROENCAPSULATION M, P183
[9]   Atovaquone and rifabutine-loaded nanocapsules: Formulation studies [J].
Dalencon, F ;
Amjaud, Y ;
Lafforgue, C ;
Derouin, F ;
Fessi, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 153 (01) :127-130
[10]   RIFAMPICIN-CARRYING POLY(D,L-LACTIDE) MICROSPHERES - LOADING AND RELEASE [J].
DENKBAS, EB ;
KAITIAN, X ;
TUNCEL, A ;
PISKIN, E .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1995, 6 (09) :815-825